Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SYF

Synchrony Financial Reports $101.7B in Loan Receivables

Synchrony Financial ended May with loan receivables of $101.7 billion, up from $100.9 billion at the end of April and $99.9 billion a year earlier.

The company’s 30-plus-day delinquency rate improved to 4.2% in May from 4.3% in April and 4.7% in February. A year earlier, the delinquency rate was also 4.2%.

Net charge-offs were 5.5% in May, unchanged from April but down from 5.8% in March and February. Compared with May 2025, when the rate was 5.1%, the May 2026 reading was up 0.4 percentage points.

After the recovery adjustment, the adjusted net charge-off rate was 5.4% in May, down from 5.6% in April and 5.8% in March and February. Versus May 2025, the adjusted rate rose from 5.2% to 5.4%.

Average loan receivables, including held for sale, increased to $100.6 billion in May from $100.2 billion in April and $99.2 billion in May 2025. Loan receivables held for sale were zero in May, after sitting at $0.2 billion in each month from September through December 2025 and again in June through August 2025.

The month also came with a slightly lower recovery adjustment of negative 0.1%, compared with positive 0.1% in April and flat in March and February. As a result of these announcements, the company's shares have moved 2.76% on the market, and are now trading at a price of $72.495. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS